Follow The Short Interest: Cyanotech Corporation (NASDAQ:CYAN) Can’t Be More Risky. Short Interest Increased

November 30, 2016 - By Adrian Mccoy   ·   0 Comments

Follow The Short Interest: Cyanotech Corporation (NASDAQ:CYAN) Can't Be More Risky. Short Interest Increased

The stock of Cyanotech Corporation (NASDAQ:CYAN) registered an increase of 25% in short interest. CYAN’s total short interest was 16,500 shares in November as published by FINRA. Its up 25% from 13,200 shares, reported previously. With 2,800 shares average volume, it will take short sellers 6 days to cover their CYAN’s short positions. The short interest to Cyanotech Corporation’s float is 0.44%. The stock last traded at $3.85 per share. It is down 21.43% since April 27, 2016 and is downtrending. It has underperformed by 26.66% the S&P500.

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company has a market cap of $21.55 million. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. It currently has negative earnings. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.

Insitutional Activity: The institutional sentiment increased to 6 in 2016 Q2. Its up 4.00, from 2 in 2016Q1. The ratio increased, as 1 funds sold all CYANOTECH CORP shares owned while 1 reduced positions. 1 funds bought stakes while 3 increased positions. They now own 1.13 million shares or 0.49% more from 1.12 million shares in 2016Q1.
Deutsche Comml Bank Ag holds 88 shares or 0% of its portfolio. Blackrock Institutional Tru Na last reported 10,562 shares in the company. Blackrock Fund Advsr has 755 shares for 0% of their US portfolio. Renaissance Ltd has invested 0% of its portfolio in CYANOTECH CORP (NASDAQ:CYAN). Salem Investment Counselors has 15,178 shares for 0.01% of their US portfolio. Wells Fargo And Mn, a California-based fund reported 875,150 shares. California Employees Retirement has 19,300 shares for 0% of their US portfolio. Morgan Stanley holds 1,500 shares or 0% of its portfolio. Vanguard Group Inc Inc accumulated 25,563 shares or 0% of the stock. Royal Bancorp Of Canada accumulated 0% or 500 shares. Moreover, Coastline has 0.09% invested in CYANOTECH CORP (NASDAQ:CYAN) for 82,400 shares.

CYAN Company Profile

Cyanotech Corporation, incorporated on March 3, 1980, is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body’s natural inflammatory response, to enhance skin, and to support eye and joint health. The Firm cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived.

More important recent CYANOTECH CORP (NASDAQ:CYAN) news were published by: Bizjournals.com which released: “Hawaii-based Cyanotech Corp. embroiled in legal case involving shareholder” on May 27, 2016, also Streetinsider.com published article titled: “Meridian OHC Partners Changes Filing Status on Cyanotech Corp (CYAN) from …”, Bizjournals.com published: “Cyanotech CEO resigns, founder steps in for the interim” on April 04, 2016. More interesting news about CYANOTECH CORP (NASDAQ:CYAN) was released by: Bizjournals.com and their article: “Kailua-Kona-based Cyanotech reports second-quarter financials” with publication date: November 12, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Adrian Mccoy

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>